Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Jacobus R B J, Brouwers"'
Autor:
Robert Y. van der Velde, Jacobus R. B. J. Brouwers, Piet P. Geusens, Willem F. Lems, Joop P. W. van den Bergh
Publikováno v:
Food & Nutrition Research, Vol 58, Iss 0, Pp 1-12 (2014)
Background: Calcium and vitamin D play an essential role in bone metabolism but deficiency and/or inadequate intake are common. Objectives: To describe a practical approach based on the literature regarding clinically important aspects of calcium and
Externí odkaz:
https://doaj.org/article/db12e9eca1e04bc3ae3f2e317e8bf999
Autor:
Niek J. de Wit, Andrea M.H. Bours, Johanna T. W. Snijkers, Daniel Keszthelyi, Annieke S. de Ruiter-van der Ploeg, Ben J.M. Witteman, Zsa Zsa R. M. Weerts, Henderik W. Frijlink, Jacobus R. B. J. Brouwers, Ad A.M. Masclee, Brigitte A. B. Essers, Jean W M Muris, C. H. M. Clemens, Jan Tack, Daisy Jonkers, Bjorn Winkens
Publikováno v:
Gastroenterology, 158(1), 123. W.B. Saunders Ltd
Gastroenterology, 158(1), 123-136
Gastroenterology 158 (2020) 1
Gastroenterology, 158(1), 123-136. Elsevier Saunders
Gastroenterology, 158(1):158, 123-136. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 158(1), 123-136
Gastroenterology 158 (2020) 1
Gastroenterology, 158(1), 123-136. Elsevier Saunders
Gastroenterology, 158(1):158, 123-136. W B SAUNDERS CO-ELSEVIER INC
BACKGROUND & AIMS: Peppermint oil is frequently used to treat irritable bowel syndrome (IBS), despite a lack of evidence for efficacy from high-quality controlled trials. We studied the efficacy and safety of small-intestinal-release peppermint oil i
Autor:
Merlijn W J van Leent, Jelena Stevanović, Frank G Jansman, Maarten J Beinema, Jacobus R B J Brouwers, Maarten J Postma
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135054 (2015)
Vitamin-K antagonists (VKAs) present an effective anticoagulant treatment in deep venous thrombosis (DVT). However, the use of VKAs is limited because of the risk of bleeding and the necessity of frequent and long-term laboratory monitoring. Therefor
Externí odkaz:
https://doaj.org/article/d05d87f0cd8d4e94aaea808f76dea3cd
Autor:
Maarten J. Postma, Jaap Nanninga, Jan G Maring, Bob Wilffert, Max L. Stek, Arne J. Risselada, Liesbeth Vleugel, Eelko Hak, Elizabeth J J Berm, Richard C. Oude Voshaar, Hans Mulder, Jurjen van der Schans, Kaspar Ditters, Rob J. van Marum, Rob M. Kok, Paul A. F. Jansen, Jacobus R. B. J. Brouwers, Laura Breuning, Ron H.N. van Schaik
Publikováno v:
van der Schans, J, Hak, E, Postma, M, Breuning, L, Brouwers, J R B J, Ditters, K, Jansen, P A F, Kok, R M, Maring, J G, van Marum, R, Mulder, H, Nanninga, J, Oude Voshaar, R C, Risselada, A J, Vleugel, L, Stek, M, van Schaik, R H N, Berm, E J J & Wilffert, B 2019, ' Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine : A Pragmatic Randomized Controlled Trial (CYSCE Trial) ', Journal of Clinical Psychopharmacology, vol. 39, no. 6, pp. 583-590 . https://doi.org/10.1097/JCP.0000000000001129
Journal of Clinical Psychopharmacology, 39(6), 583-590. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams & Wilkins
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams and Wilkins
Journal of Clinical Psychopharmacology, 39(6), 583-590. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams & Wilkins
Journal of Clinical Psychopharmacology, 39(6), 583-590. Lippincott Williams and Wilkins
PURPOSE/BACKGROUND: The duration of untreated depression is a predictor for poor future prognosis, making rapid dose finding essential. Genetic variation of the CYP2D6 isoenzyme can influence the optimal dosage needed for individual patients. The aim
Publikováno v:
Scientifica, Vol 2012 (2012)
The epidemiological transition, with a rapid increase in the proportion in the global population aged over 65 years from 11% in 2010 to 22% in 2050 and 32% in 2100, represents a challenge for public health. More and more old persons have multimorbidi
Externí odkaz:
https://doaj.org/article/cdc28d40ad1945bea31a8f3866598937
Autor:
Elizabeth J J Berm, Jacobus R. B. J. Brouwers, Laura Breuning, Ron H.N. van Schaik, Liesbeth Vleugel, Eelko Hak, Hans Mulder, J. G. Maring, Max L. Stek, Maarten J. Postma, Richard C. Oude Voshaar, Jurjen van der Schans, Kaspar Ditters, Jaap Nanninga, Rob J. van Marum, Bob Wilffert, Arne J. Risselada, Rob M. Kok, Paul A. F. Jansen
Publikováno v:
Journal of Clinical Psychopharmacology, 40(5), 443-443. LIPPINCOTT WILLIAMS & WILKINS
Publikováno v:
Br J Clin Pharmacol
British Journal of Clinical Pharmacology, 85(11), 2479-2486. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 85(11), 2479-2486. Wiley-Blackwell Publishing Ltd
Biosimilars of low molecular weight heparins (LMWHs) are more alike the originator than different branded LMWHs. The latter differ largely in molecular weight, anti-FXa/anti-FIIa ratio and antithrombin binding. The Food and Drug Administration and Eu
Autor:
Anton J. M. Loonen, Nikolay A. Bokhan, Lisanne M Geers, Bob Wilffert, Evgeniy V. Rudikov, N. Vyalova, A. F. Y. Al Hadithy, Petros Pechlivanoglou, Svetlana A. Ivanova, Jacobus R. B. J. Brouwers, Arkadiy V. Semke, Olga Yu Fedorenko
Publikováno v:
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 50, 172-177. PERGAMON-ELSEVIER SCIENCE LTD
Background: Tardive dyskinesia (TD) is a potentially irreversible consequence of long term treatment with antipsychotic drugs which is according to a well-known theory believed to be related to oxidative stress induced neurotoxicity. Dehydroepiandros
Autor:
Lotte Jacobs, Olle ten Cate, Dick J. de Wildt, Paul A. F. Jansen, Jacobus R. B. J. Brouwers, Carolina J. P. W. Keijsers, Larissa van Hensbergen
Publikováno v:
British Journal of Clinical Pharmacology. 74:762-773
AIMS Given the reported high rates of medication errors, especially in elderly patients, we hypothesized that current curricula do not devote enough time to the teaching of geriatric pharmacology. This review explores the quantity and nature of geria
Publikováno v:
Drugs & Aging. 29:615-625
In the treatment of chronic malignant and non-malignant pain, opioids are used as strong analgesics. Frail elderly patients often have multiple comorbidities and use multiple medicines, leading to an increased risk of clinically relevant drug-drug an